Alcon AG | ALC - Operating Expenses

Stock Price
64.28
Daily Change
0.50 0.78%
Monthly
2.59%
Yearly
-19.81%
Q1 Forecast
62.72

Alcon AG reported $2.28B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AstraZeneca USD 12.53B 4.16B Dec/2025
Bayer EUR 10.2B 523M Sep/2025
Essilor EUR 13.09B 1.07B Dec/2025
Fresenius EUR 4.91B 110M Sep/2025
Fresenius Medical Care EUR 4.43B 73.91M Sep/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.11B 117M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Philips EUR 4.38B 405M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Smith & Nephew USD 2.52B 84M Dec/2025
Sonova Holding CHF 1.52B 59.9M Dec/2025
UCB EUR 2.36B 108M Dec/2024